COVID-19 Solutions for Consumer & Company
Home test kit
Our pioneering COVID-19 test uses patented Randox Biochip Technology to accurately and reliably diagnose COVID-19.
The convenient home sample collection kit can be purchased securely online and includes an easy to use swab, allowing you to take your sample in the comfort of your own home. Simply collect your sample and return to Randox via courier, results will be emailed to you within 24 hours of sample receipt.
The biochip comprises two tests for COVID-19, one specific and one confirmatory as recommended by the WHO. Trusted by many, the service is widely used in the sports industry and in the UK government’s national COVID-19 testing programme, with Randox responsible for up to 17% of the total tests carried out.
With a Randox Health antibody test, you can find out if you have already had COVID-19. Now available in all Randox Health clinics, this simple blood test is designed to detect COVID-19 antibodies.
Our highly accurate antibody test can be purchased as a stand-alone test, as an “add-on” to our popular Everyman & Everywoman packages or as part of our exclusive signature package.
Antibodies are produced by the body in response to infection. A positive result therefore indicates previous COVID-19 infection, whilst a negative result indicates that it is unlikely you have been infected with the virus.
Randox Health can help manage COVID-19 risk and spread in your organisation with our rapid back to business service. A simple swab test is all that is required to diagnose active COVID-19 infections, facilitating appropriate containment measures and reducing further spread of disease.
This rapid testing service is used within the UK government’s national COVID-19 testing programme, with Randox responsible for up to 17% of total tests carried out.
The flexible service can be tailored to meet your specific needs, with the option to include a sample collection officer or secure Randox courier service.
Randox | Coronavirus COVID-19 Array – Lo-Plex Molecular Assay for SARS-CoV-2 (COVID-19)
Utilising patented biochip technology the Randox COVID-19 Array comprises two targets; SARS-CoV-2 and sarbecovirus (SARS, SARS like, SARS-CoV-2) in line with WHO and CDC recommendations. The target genes represent conserved regions of the genome and have been chosen due to their sensitivity and specificity.
Randox | Extended Coronavirus Assay – Hi-Plex Molecular Assay for SARS-CoV-2 and 9 other viral targets
The Randox Extended Coronavirus Array comprises 6 strains of coronavirus including SARS-CoV-2. The wider panel delivers a more comprehensive respiratory screen allowing differentiation between COVID-19 and other respiratory viruses with similar symptoms.
Randox | Evidence Investigator
The Evidence Investigator is a compact semi-automated benchtop analyser. It is the perfect fit for medium throughput laboratories seeking maximum use of bench space without compromising on the volume of samples processed.
- Estimated turnaround time of less than 5 hours
- Medium to high throughput (Capable of processing 54 samples and 540 test results in less than 5 hours)
- Detection from nucleic acid
- Batch testing
- Suitable for laboratory setting
- Comprehensive test menu
Randox Laboratories have developed a game-changing point of care coronavirus test. The Vivalytic Viral Respiratory Tract Infection (VRI) Array can identify SARS-CoV-2 (COVID-19) and differentiate it from nine other respiratory infections with similar symptoms, including influenza and all known coronaviruses.
Vivalytic is a point of care platform designed and engineered by Bosch. The platform is powered by Randox Multiplex Biochip Technology, enabling multiple results from one patient sample. Combining world leading Bosch engineering with innovative Randox molecular tests, provides the healthcare industry with precise diagnostics to implement targeted treatment.
The Vivalytic system is a fully-automated, cartridge-based platform capable of both Hi-Plex and Lo-Plex testing. The cartridges are fully-sealed which minimises the risk of contamination, require room temperature storage (space-saving), contain all the reagents on-board the cartridge and utilises end point PCR.
Randox | QCMD Coronavirus EQA Scheme
As a global leader in EQA for molecular infectious disease testing, QCMD offer several solutions for SARS-CoV-2 designed to evaluate method performance.
The SARS-CoV-2 EQA Study is designed to assess the ability of laboratories to detect the virus at clinically relevant levels and will assess assay specificity.
The Respiratory I Plus EQA programme covers SARS-CoV-2 in addition to other respiratory viruses including influenza and RSV and is ideal for laboratories using multiplex methods.
In response to the current Coronavirus outbreak, Qnostics, a world leading manufacturer of QC solutions for molecular infectious disease testing has developed a range of products designed to support the validation, verification and performance monitoring of molecular assays used in the testing of SARS-CoV-2 (COVID-19).
Randox Discovery | The Benchtop Lab
The Randox Discovery is an exciting and disruptive molecular and immunoassay analyser capable of consolidating the normal workload of multiple laboratories into one compact benchtop platform.
This fully automated analyser comes with an extensive test menu which covers SARS-CoV-2 array (COVID-19) as well as an extended Coronavirus array.